Sandoz Gmbh

Francedillaois Cardinaux

Rainer Albert

Wilfried Bauer

Janos Pless

Andreas Rummelt

Christine Oechslein

A pharmaceutical composition adapted for nasal administration and comprising hPTH or a N-terminal fragment thereof. Preferred carriers are optionally coated celluloses.

Nasal pharmaceutical composition

Peptide derivatives selected from (i) a calcitonin peptide and a LHRH antagonist peptide modified by at least one sugar residue and/or at least one short polyhydroxy compound or derivative, and (ii) a calcitonin peptide modified by at least one formyl and/or at least C.sub.3-5 alkyl attached to an amino group other than a N-terminal amino group, and (iii) a calcitonin peptide modified by a combination of said substituents, with the provisos that

Growing community of inventors

Seewen, Switzerland

Francedillaois Cardinaux